Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Conference Correspondent
ASCO 2015
ASCO 2015 Highlights
Direct-to-Consumer Genetics/Genomics: A “New Paradigm” in Providing Healthcare Information
Genomic Testing
July/August 2010, Vol 1, No 3
Read Article
Clinical Trials: Understanding Cost, Coverage Implications
Clinical Trials
July/August 2010, Vol 1, No 3
Read Article
How Will Costs Be Contained in the New Healthcare Environment?
Economics & Value
July/August 2010, Vol 1, No 3
Read Article
Adherence to Colon Cancer Chemotherapy Guidelines Depends on Treatment Setting
Chemotherapy
,
Personalized Medicine
July/August 2010, Vol 1, No 3
Read Article
Reasons for Breast Cancer Care Disparities Remain Unclear
Disparities in Oncology
July/August 2010, Vol 1, No 3
Read Article
Comparative Effectiveness Research Will Help Guide Health Policy
Health Policy
,
Policies & Guidelines
July/August 2010, Vol 1, No 3
Read Article
Pathway Compliance Reduces Drug, Nondrug Expenses
Pathways
,
Policies & Guidelines
July/August 2010, Vol 1, No 3
Evaluation of a regional payer-based pay-for-quality (P4Q)oncology program showed thatPathways programs can greatly reduce the cost of cancer care by slowingthe growth rate of both drug andnondrug expenses.
Read Article
The New Face of the Community Oncology Practice
Community Oncology
,
Economics & Value
July/August 2010, Vol 1, No 3
Read Article
Cost Considerations Change Dialogue
ASCO Annual Meeting
,
ASCO
July/August 2010, Vol 1, No 3
Although financial concerns are increasingly influencing choices in cancer therapy, barriers to cost discussions between physicians and patients often limit the scope of such discussions.
Read Article
Do End-of-Life Products Deserve Special Treatment?
End-of-Life Care
,
ISPOR Annual Meeting
,
Policies & Guidelines
July/August 2010, Vol 1, No 3
Read Article
Page 324 of 330
321
322
323
324
325
326
327
Top Trending Articles
1.
FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
2.
FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency
3.
ACCC Federal Policy Update Highlights Key Risks and Opportunities for Oncology Practices in 2026
Meg Barbor, MPH
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma